CellChorus logo

CellChorus

Emerging

Houston biotech with visual AI TIMING platform analyzing individual cell behaviors in nanowell grids; $5.78M raised plus NIH STTR grant targeting CAR-T quality release and drug discovery screening.

40
AI Score
Grade C
AI Visibility Score (Beta)
HealthcareWebsiteUpdated October 2026

Company Overview

About CellChorus

CellChorus is a Houston-based biotechnology company developing the TIMING (Time-lapse Imaging Microscopy in Nanowell Grids) platform — a visual AI system that analyzes individual cell behaviors over time in nanoscale grid arrays to characterize how cells interact, move, and function, enabling drug developers and cell therapy manufacturers to optimize their biologics and cell therapies with unprecedented single-cell resolution. Founded in 2021 and backed with $5.78 million in equity funding plus $3.4 million in non-dilutive grants including a $2.5 million NIH STTR Fast-Track grant in partnership with University of Houston, CellChorus serves biotech researchers, cell therapy manufacturers, and pharmaceutical companies.

Business Model & Competitive Advantage

CellChorus' TIMING platform captures time-lapse microscopy data of individual cells (T-cells, NK cells, CAR-T cells) in nanowell grids and applies computer vision AI to analyze cell-to-cell interactions, killing behaviors, and functional characteristics that static endpoint assays miss. For cell therapy developers (CAR-T, NK cell therapies), this means being able to characterize the potency and killing behavior of manufactured immune cells before infusing them in patients — a quality control capability that current release assays cannot provide. For drug discovery, the platform enables screening drug candidates by their effect on individual cell behavior rather than bulk population averages.

Competitive Landscape 2025–2026

In 2025, CellChorus competes in the cell analysis, bioprocessing analytics, and drug discovery screening market with Sartorius Incucyte (live cell imaging), BioTek Cytation (multimode imaging), and traditional flow cytometry platforms for cell therapy characterization and drug screening. The cell therapy market (CAR-T, NK cell, TIL therapies) has grown significantly with multiple FDA approvals (Kymriah, Yescarta, Carvykti) driving investment in cell therapy manufacturing quality systems. The NIH grant reflects academic validation of the TIMING platform's scientific approach. The 2025 strategy focuses on cell therapy quality release testing partnerships with CDMOs (contract development and manufacturing organizations), expanding the drug discovery screening use case, and building the regulatory science documentation that supports FDA Quality by Design submissions.

Founded
2021
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Emerging Innovator

CellChorus is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

40
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Epic Systems logo

Epic Systems

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Oracle Health logo

Oracle Health

Healthcare
HealthtechNorth AmericaB2b

Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve

Pfizer logo

Pfizer

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan

Moderna logo

Moderna

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép

Amgen logo

Amgen

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic

Compare CellChorus with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For CellChorus

Claim This Profile

Are you from CellChorus? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim CellChorus Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention CellChorus vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →